2/24
09:18 am
maia
MAIA Biotechnology's Phase 3 Momentum Demonstrates Potential Breakthrough Anticancer Opportunity in $50 Billion Immunotherapy Market [Yahoo! Finance]
High
Report
MAIA Biotechnology's Phase 3 Momentum Demonstrates Potential Breakthrough Anticancer Opportunity in $50 Billion Immunotherapy Market [Yahoo! Finance]
2/24
08:45 am
maia
MAIA Biotechnology’s Phase 3 Momentum Demonstrates Potential Breakthrough Anticancer Opportunity in $50 Billion Immunotherapy Market
Medium
Report
MAIA Biotechnology’s Phase 3 Momentum Demonstrates Potential Breakthrough Anticancer Opportunity in $50 Billion Immunotherapy Market
1/20
10:15 am
maia
MAIA Biotechnology Advances Ateganosine Cancer Treatment Program, Outlines Targeted 2026 Clinical Milestones and Growth Momentum
High
Report
MAIA Biotechnology Advances Ateganosine Cancer Treatment Program, Outlines Targeted 2026 Clinical Milestones and Growth Momentum
1/20
08:18 am
maia
Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA) [Yahoo! Finance]
Medium
Report
Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA) [Yahoo! Finance]
12/24
08:13 am
maia
MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings [Yahoo! Finance]
Medium
Report
MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings [Yahoo! Finance]
12/24
08:01 am
maia
MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings
Medium
Report
MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings
12/16
04:15 pm
maia
MAIA Biotechnology Announces $1.51 Million Private Placement
Medium
Report
MAIA Biotechnology Announces $1.51 Million Private Placement
12/11
01:45 pm
maia
MAIA's Ateganosine Surges Ahead with Breakthrough Momentum as Pivotal Phase 3 Trial Initiates [Yahoo! Finance]
Medium
Report
MAIA's Ateganosine Surges Ahead with Breakthrough Momentum as Pivotal Phase 3 Trial Initiates [Yahoo! Finance]
12/11
01:00 pm
maia
MAIA’s Ateganosine Surges Ahead with Breakthrough Momentum as Pivotal Phase 3 Trial Initiates
Medium
Report
MAIA’s Ateganosine Surges Ahead with Breakthrough Momentum as Pivotal Phase 3 Trial Initiates
12/11
09:14 am
maia
MAIA Biotechnology Announces First Patient Dosed in THIO-104 Phase 3 Pivotal Trial Evaluating Ateganosine as Third-Line Treatment for Advanced Non-Small Cell Lung Cancer [Yahoo! Finance]
High
Report
MAIA Biotechnology Announces First Patient Dosed in THIO-104 Phase 3 Pivotal Trial Evaluating Ateganosine as Third-Line Treatment for Advanced Non-Small Cell Lung Cancer [Yahoo! Finance]
12/11
09:00 am
maia
MAIA Biotechnology Announces First Patient Dosed in THIO-104 Phase 3 Pivotal Trial Evaluating Ateganosine as Third-Line Treatment for Advanced Non-Small Cell Lung Cancer
High
Report
MAIA Biotechnology Announces First Patient Dosed in THIO-104 Phase 3 Pivotal Trial Evaluating Ateganosine as Third-Line Treatment for Advanced Non-Small Cell Lung Cancer
12/11
08:27 am
maia
MAIA Leadership Continues Insider Buying in 2025 and Trial Data Signals Breakout Potential [Yahoo! Finance]
High
Report
MAIA Leadership Continues Insider Buying in 2025 and Trial Data Signals Breakout Potential [Yahoo! Finance]
12/11
08:00 am
maia
MAIA Leadership Continues Insider Buying in 2025 and Trial Data Signals Breakout Potential
High
Report
MAIA Leadership Continues Insider Buying in 2025 and Trial Data Signals Breakout Potential
12/10
02:42 pm
maia
MAIA Takes Aim at a $50B Immunotherapy Market with Breakthrough Telomere-Targeting Approach [Yahoo! Finance]
Low
Report
MAIA Takes Aim at a $50B Immunotherapy Market with Breakthrough Telomere-Targeting Approach [Yahoo! Finance]
12/10
02:00 pm
maia
MAIA Takes Aim at a $50B Immunotherapy Market with Breakthrough Telomere-Targeting Approach
Low
Report
MAIA Takes Aim at a $50B Immunotherapy Market with Breakthrough Telomere-Targeting Approach
12/1
09:36 am
maia
MAIA Biotechnology Announces Open Market Purchases by CEO and Directors [Yahoo! Finance]
Medium
Report
MAIA Biotechnology Announces Open Market Purchases by CEO and Directors [Yahoo! Finance]
12/1
09:17 am
maia
MAIA Biotechnology Announces Open Market Purchases by CEO and Directors
Medium
Report
MAIA Biotechnology Announces Open Market Purchases by CEO and Directors